Hattie Hayes

The phase 3 LUCERNE and TENAYA trials suggested that faricimab may allow clinicians to extend the interval between injections to up to 16 weeks after an initial loading phase

Alcon acquired the historic ophthalmic instrument company in 2000

In the European Union and the United Kingdom, aflibercept 8mg (Eylea HD in the US) is currently approved for neovascular age-related macular degeneration and diabetic macular oedema

Patients with GCA, an autoimmune disease, are at risk for sudden vision loss which can be permanent

Nordic Pharma plans to announce commercialisation details in the near future for the dry eye disease treatment

Treatment regimens with long-duration therapies continue to be a conversation starter among retina specialists

The Congress on Controversies in Ophthalmology highlights debates, but also discussions

Retina topics serve as the backbone of the scientific programme at this year’s Congress on Controversies in Ophthalmology

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss

The lens will be available with the Monarch IV manual delivery system in Q2 and the AutonoMe Automated Pre-Loaded Delivery System in Q3

The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases

After a successful inaugural WOS in 2024, the congress will feature new lectures and wetlabs in its sophomore year

SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial

A large-scale study indicates women are more likely to develop the inherited corneal condition

The UN Friends of Vision group meeting coincided with International Women's Day and the UN Commission on the Status of Women

A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden

The event will include presentations on artificial intelligence, ocular imaging and surgical topics

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease

This year, the European Society of Cataract and Refractive Surgeons has partnered with the Hellenic Society of Intraocular Implant and Refractive Surgery

The Visumax 800 boasts a faster laser pulse repetition rate for shorter procedures

Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision

The biosimilar to aflibercept (Eylea) has already received approval in the EU and US

Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action

According to Apellis and Sobi, pegcetacoplan (Aspaveli) first received marketing authorisation for treatment of paroxysmal nocturnal hemoglobinuria

The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March

Professor Anat Loewenstein, MD, speaks about her presentation from the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting

The company shared 5-year results for lenadogene nolparvovec (Lumevoq), administered unilaterally and bilaterally to patients with Leber Hereditary Optic Neuropathy